Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$165,602,023
-$13,301,494 QoQ
Shares Held
2,562,309
-3.6% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 74.30040639126662.ToString("F0")%
Shared 0.ToString("F0")%
None 25.699593608733373.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. HALO ranks #17 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $165,602,023 | 2,562,309 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $178,903,517 | 2,658,299 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $127,435,577 | 1,737,600 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $92,002,617 | 1,768,601 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $123,247,348 | 1,931,474 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $78,741,390 | 1,646,965 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $93,605,023 | 1,635,308 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $67,238,509 | 1,284,158 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $55,139,373 | 1,355,442 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $47,350,077 | 1,281,117 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $39,514,647 | 1,034,415 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $39,456,354 | 1,093,883 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $42,807,738 | 1,120,915 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $63,835,764 | 1,121,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $34,164,176 | 864,041 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,812,016 | 859,364 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $16,925,866 | 424,420 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $15,023,941 | 373,637 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,561,194 | 382,527 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,388,948 | 603,148 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $28,930,565 | 693,945 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $22,260,451 | 521,200 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $13,672,563 | 520,265 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,814,095 | 291,462 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,763,820 | 542,736 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||